NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 01 04:00PM ET
3.93
Dollar change
+0.10
Percentage change
2.61
%
IndexRUT P/E- EPS (ttm)-0.97 Insider Own2.92% Shs Outstand60.05M Perf Week17.31%
Market Cap235.39M Forward P/E41.23 EPS next Y0.10 Insider Trans-66.03% Shs Float58.15M Perf Month82.79%
Enterprise Value160.90M PEG- EPS next Q-0.24 Inst Own56.16% Short Float7.73% Perf Quarter-31.65%
Income-57.70M P/S- EPS this Y41.27% Inst Trans-13.80% Short Ratio2.39 Perf Half Y-21.71%
Sales0.00M P/B3.71 EPS next Y117.27% ROA-49.21% Short Interest4.49M Perf YTD-21.24%
Book/sh1.06 P/C2.61 EPS next 5Y61.78% ROE-65.19% 52W High7.20 -45.42% Perf Year15.59%
Cash/sh1.50 P/FCF- EPS past 3/5Y4.24% 15.99% ROIC-73.12% 52W Low1.14 244.74% Perf 3Y6.79%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility9.15% 8.84% Perf 5Y-5.07%
Dividend TTM- EV/Sales- EPS Y/Y TTM-90.67% Oper. Margin- ATR (14)0.27 Perf 10Y-54.30%
Dividend Ex-Date- Quick Ratio6.39 Sales Y/Y TTM- Profit Margin- RSI (14)75.64 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio6.39 EPS Q/Q-21.91% SMA2027.49% Beta0.89 Target Price8.67
Payout- Debt/Eq0.24 Sales Q/Q- SMA5048.91% Rel Volume0.49 Prev Close3.83
Employees9 LT Debt/Eq0.24 EarningsMay 01 SMA200-14.73% Avg Volume1.88M Price3.93
IPOMay 02, 2014 Option/ShortYes / Yes EPS/Sales Surpr.33.55% -33.33% Trades Volume922,743 Change2.61%
Date Action Analyst Rating Change Price Target Change
Apr-03-24Upgrade Oppenheimer Perform → Outperform $10
Apr-02-24Resumed H.C. Wainwright Buy $10
Apr-27-22Resumed H.C. Wainwright Buy $15
Feb-08-21Initiated H.C. Wainwright Buy $26
Dec-16-20Initiated Berenberg Buy $32
Oct-30-20Initiated Jefferies Buy $24
Oct-16-20Initiated BTIG Research Buy $29
Sep-22-20Initiated Alliance Global Partners Buy $32
May-12-20Initiated Oppenheimer Outperform $12
Dec-04-18Initiated Citigroup Buy $23
Jun-26-25 07:00AM
Jun-17-25 07:00AM
May-29-25 07:01AM
May-05-25 06:34PM
04:00PM
11:42AM Loading…
Apr-29-25 11:42AM
Apr-28-25 09:00PM
Apr-24-25 01:57PM
Apr-21-25 09:00PM
10:52AM
08:49AM
Apr-18-25 02:52PM
11:23AM
Apr-17-25 07:00AM
Apr-16-25 05:23PM
09:00PM Loading…
Apr-15-25 09:00PM
Apr-11-25 01:26PM
07:43AM
Apr-10-25 09:30AM
Apr-09-25 05:00PM
Apr-08-25 04:51AM
03:08AM
Apr-06-25 07:08AM
Apr-03-25 10:24AM
08:00AM
Mar-10-25 07:00AM
Feb-05-25 03:24AM
Feb-04-25 07:00AM
Jan-20-25 03:28PM
Dec-09-24 10:05AM
07:00AM Loading…
Dec-02-24 07:00AM
Nov-18-24 07:00AM
Nov-14-24 07:00AM
Oct-31-24 07:00AM
Oct-03-24 07:00AM
Sep-05-24 07:00AM
Aug-30-24 10:38AM
Aug-09-24 06:32AM
Aug-08-24 07:00AM
Aug-07-24 04:01PM
Jun-20-24 07:00AM
Jun-14-24 06:32AM
Jun-13-24 07:00AM
Jun-12-24 07:00AM
May-29-24 07:00AM
May-14-24 09:40AM
May-08-24 03:12PM
07:00AM
May-03-24 08:52AM
Apr-25-24 07:00AM
Apr-22-24 09:40AM
Apr-18-24 07:00AM
Apr-06-24 06:37AM
Apr-04-24 12:36PM
Apr-03-24 02:58PM
Mar-28-24 07:00AM
Mar-27-24 01:21PM
Mar-13-24 02:33AM
Mar-06-24 09:40AM
Feb-06-24 07:00AM
Jan-04-24 07:00AM
Dec-19-23 07:27AM
07:05AM
07:00AM
Dec-18-23 04:01PM
Dec-06-23 11:55AM
Dec-05-23 09:00AM
Nov-27-23 04:07PM
Nov-01-23 10:34AM
07:05AM
Oct-18-23 08:30AM
Oct-17-23 10:13AM
Aug-28-23 10:22AM
Jul-20-23 09:55AM
Jul-06-23 07:00AM
Jun-29-23 07:00AM
05:20AM
Jun-28-23 04:01PM
Jun-27-23 12:03PM
07:00AM
Jun-26-23 04:01PM
Jun-23-23 07:00AM
Jun-21-23 09:34AM
Jun-16-23 10:26AM
Jun-15-23 02:52PM
07:08AM
07:00AM
Jun-14-23 04:01PM
Jun-02-23 07:00AM
May-07-23 07:30AM
May-04-23 07:00AM
Apr-13-23 07:00AM
Apr-06-23 07:00AM
Mar-30-23 07:00AM
Mar-16-23 07:00AM
Mar-11-23 02:59AM
Mar-09-23 11:05PM
07:00AM
Mar-02-23 07:00AM
Mar-01-23 07:00AM
Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PERCEPTIVE ADVISORS LLC10% OwnerApr 03 '25Sale1.423,400,0004,828,0005,875,851Apr 07 06:43 PM
Machatha StephenChief Development OfficerAug 12 '24Sale4.7416,04175,975236,771Aug 14 04:24 PM
Greenberg BruceSee RemarksAug 12 '24Sale4.7410,83451,313126,382Aug 14 04:24 PM
Greenberg BruceOfficerAug 12 '24Proposed Sale5.1010,83455,253Aug 12 06:07 PM
Machatha StephenOfficerAug 12 '24Proposed Sale5.1016,04181,809Aug 12 05:45 PM